SCHEMBL19968355

SCHEMBL19968355

Fc1cc(F)cc(P(I)c2cc(F)cc(F)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA9 Q16790 1/20 0.38
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506225 0.73 CA12 (0.42) CA12CA1CA9CES2CES1
SCHEMBL19968343 0.73 CES2 (0.36) CES2CES1
SCHEMBL449836 0.71
SCHEMBL2881917 0.69 CA12 (0.38) CA12CA1CA9CES2CES1
SCHEMBL8610016 0.69 CA12 (0.45) CA12CA1CA9CES2CES1
SCHEMBL19968353 0.69 IDO1 (0.39) CA1CA9CES2CES1
SCHEMBL8019916 0.69 CA12 (0.38) CA12CA1CA9CES2CES1
SCHEMBL8609628 0.69 CES2 (0.39) CA12CA1CA9CES2CES1
SCHEMBL12621192 0.69 CA12 (0.45) CA12CA1CA9CES2CES1
SCHEMBL19968364 0.69 CES2 (0.33) CA12CA1CA9CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113896607-B Olefin oligomerization process using a catalyst comprising a chromium complex having a phosphacycle-containing ligand 陶氏环球技术有限责任公司 2024-04-16 CN disclosed
US-20220176363-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2022-06-09 US disclosed
CN-107548385-B Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand 陶氏环球技术有限责任公司 2022-01-21 CN disclosed
CN-113896607-A Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand 陶氏环球技术有限责任公司 2022-01-07 CN disclosed
CN-107592863-B Chromium complexes with ligands containing phosphacycles and olefin oligomerization catalysts therefrom 陶氏环球技术有限责任公司 2021-09-10 CN disclosed
CN-107567355-B Phosphacycle-containing ligands for chromium complexes and olefin oligomerization catalysts therefrom 陶氏环球技术有限责任公司 2021-07-23 CN disclosed
US-20210129125-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2021-05-06 US disclosed
US-10981156-B2 Chromium complex and catalyst therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2021-04-20 US disclosed
US-10919031-B2 Process for oligomerization DOW GLOBAL TECHNOLOGIES LLC (US) 2021-02-16 US disclosed
US-20200338542-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2020-10-29 US disclosed
US-10702861-B2 Process for oligomerization DOW GLOBAL TECHNOLOGIES LLC (US) 2020-07-07 US disclosed
US-20200030783-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2020-01-30 US disclosed
US-10376869-B2 Process for oligomerization DOW GLOBAL TECHNOLOGIES LLC (US) 2019-08-13 US disclosed
US-10357764-B2 Phosphacycle compound and process for production thereof DOW GLOBAL TECHNOLOGIES LLC (US) 2019-07-23 US disclosed
US-20190210013-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2019-07-11 US disclosed
US-10207262-B2 Chromium complex and catalyst therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2019-02-19 US disclosed
US-20180154344-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2018-06-07 US disclosed
US-20180071725-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210129125-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 CA12 3187/4885CA1 2491/4885CA9 3516/4885
US-20200338542-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 CA12 3187/4885CA1 2491/4885CA9 3516/4885
US-20180071725-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM OXER1, LIG1, PICALM CA12 1059/4885CA1 1187/4885CA9 2010/4885
US-10919031-B2 Process for oligomerization OXER1, NOD1, LIG1 CA12 3187/4885CA1 2491/4885CA9 3516/4885
US-10376869-B2 Process for oligomerization OXER1, NOD1, LIG1 CA12 3187/4885CA1 2491/4885CA9 3516/4885
US-10981156-B2 Chromium complex and catalyst therefrom OXER1, LIG1, PICALM CA12 1059/4885CA1 1187/4885CA9 2010/4885
US-10357764-B2 Phosphacycle compound and process for production thereof OXER1, PPIP5K2, IP6K1 CA12 1801/4885CA1 1165/4885CA9 1416/4885
US-10207262-B2 Chromium complex and catalyst therefrom OXER1, LIG1, PICALM CA12 1059/4885CA1 1187/4885CA9 2010/4885
US-20200030783-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 CA12 3187/4885CA1 2491/4885CA9 3516/4885
US-20180154344-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 CA12 3187/4885CA1 2491/4885CA9 3516/4885
US-20220176363-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 CA12 3187/4885CA1 2491/4885CA9 3516/4885
US-20190210013-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM OXER1, LIG1, PICALM CA12 1059/4885CA1 1187/4885CA9 2010/4885
US-10702861-B2 Process for oligomerization OXER1, NOD1, LIG1 CA12 3187/4885CA1 2491/4885CA9 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.